WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002032294) RADIOPHARMACEUTICAL FORMULATIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/032294    International Application No.:    PCT/US2001/050802
Publication Date: 25.04.2002 International Filing Date: 19.10.2001
Chapter 2 Demand Filed:    02.05.2002    
IPC:
A61K 51/04 (2006.01), A61K 51/12 (2006.01)
Applicants: BRACCO RESEARCH USA [US/US]; 305 College Road East, Princeton, NJ 08540 (US) (For All Designated States Except US).
CAGNOLINI, Aldo [IT/US]; (US) (For US Only).
LINDER, Karen, E. [US/US]; (US) (For US Only).
MARINELLI, Edmund, R. [US/US]; (US) (For US Only)
Inventors: CAGNOLINI, Aldo; (US).
LINDER, Karen, E.; (US).
MARINELLI, Edmund, R.; (US)
Agent: DOUROS, Timothy, J.; Clark & Elbing LLP, 101 Federal Street, Boston, MA 02110 (US).
ELBING, Karen, L.; Clark & Elbing LLP, 101 Federal Street, Boston, MA 02110 (US)
Priority Data:
60/241,782 19.10.2000 US
Title (EN) RADIOPHARMACEUTICAL FORMULATIONS
(FR) FORMULATIONS DE PRODUITS RADIOPHARMACEUTIQUES
Abstract: front page image
(EN)A method is described for inhibiting the degradation of a diagnostic or radiotherapeutic radiopharmaceutical, especially radiolabeled compounds containing reducible moieties, by including oxidants either as a part of the composition for the preparation of such radiopharmaceuticals, or by adding an oxidant to such compositions immediately after the preparation of such radiopharmaceuticals.
(FR)L'invention concerne une méthode d'inhibition de la dégradation d'un produit radiopharmaceutique de diagnostic ou de radiothérapie, précisément des composés radiomarqués contenant des fractions réductibles. Cette méthode consiste soit à incorporer des oxydants dans la composition de préparation de ces produits radiopharmaceutiques, soit à ajouter un oxydant à ces compositions immédiatement après la préparation desdits produits radiopharmaceutiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)